Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selenium Supplementation for Improving Depression in Children and Adolescents
NCT07203144Phase 2Recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Dec 2025
- Primary completion
- Apr 2027
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selenium yeast in major depressive disorder (MDD), sponsored by First Affiliated Hospital of Chongqing Medical University. Started Dec 2025; status: recruiting.
02
Drugs
selenium yeast
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT07203144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07203144.